Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 +0.28 (+3.35%)
As of: Nov 11, 2026 · 3:59 PM EST

Aspire-Lakewood Holdings (ASBP) Debt Ratio (2021 - 2026)

Updated

Aspire Biopharma Holdings' (ASBP) Debt Ratio stood at 0.07 in Q1 2026, down 96.9% from 2.23 a year earlier and down 96.1% from the prior quarter.

Analysis

Aspire-Lakewood Holdings (ASBP) Debt Ratio (2021 - 2026) Analysis & Trends

For FY2025, Aspire Biopharma Holdings' Debt Ratio came in at 1.82, down 98.3% from FY2024.

  • Across earlier years, Debt Ratio came in at 104.92 in FY2024, 0.02 in FY2023 and 0.81 in FY2021.
  • The Q1 2026 figure is the lowest quarterly Debt Ratio since Q1 2024.
  • Per Business Quant, the preceding three quarters came in at 1.82 (Q4 2025), 2.34 (Q3 2025) and 5.00 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Aspire-Lakewood Holdings 63.98 Mn 43.01 Mn -30,086.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.21
Dec 31, 2025 3.94
Sep 30, 2025 2.97
Jun 30, 2025 7.55
Mar 31, 2025 3.44
Dec 31, 2024 108.07
Sep 30, 2024 0.81
Jun 30, 2024 0.78
Mar 31, 2024 0.01
Dec 31, 2023 0.02
Dec 31, 2021 0.81
API Access

Aspire-Lakewood Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ASBP&period=max&api_key=YOUR_API_KEY